Combination of targeted multikinase inhibitor and radioiodine: a new strategy of treatment for advanced differentiated thyroid carcinoma
Advanced differentiated thyroid carcinoma (ADTC) lacks effective treatment options, and has a poor prognosis, which is an urgent clinical problem to be resolved. Targeted multikinase inhibitor(MKI) has been approved for the treatment of radioiodine refractory differentiated thyroid carcinoma, and ha...
| 1. autor: | |
|---|---|
| Format: | Artykuł |
| Język: | zho |
| Wydane: |
Editorial Office of Journal of Surgery Concepts & Practice
2023-11-01
|
| Seria: | Waike lilun yu shijian |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.qk.sjtu.edu.cn/jscp/fileup/1007-9610/PDF/1709529976247-1300245714.pdf |